4//SEC Filing
Brzeczko Albert W 4
Accession 0001104659-23-119811
CIK 0000786947other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 12:07 PM ET
Size
7.4 KB
Accession
0001104659-23-119811
Insider Transaction Report
Form 4
Brzeczko Albert W
VP Technical Affairs
Transactions
- Exercise/Conversion
Restricted Stock Unit (2021 Plan)
2023-11-20+40,000→ 0 totalExercise: $0.01→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2023-11-20+40,000→ 486,001 total
Footnotes (4)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
- [F3]Not Applicable.
- [F4]40,000 Restricted Stock Units were granted on March 16, 2022 and were 100% vested on December 31, 2022
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001455740
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 12:07 PM ET
- Size
- 7.4 KB